Introduction
The term mucin is used to describe the high molecular weight glycoproteins which are major components of mucus, the seroviscous material secreted by various epithelial tissues, and to which are attached numerous carbohydrate chains. As many as 200 closely spaced (clustered) carbohydrate chains per 250 kilodaltons of glycoprotein may be attached by a linkage between the N-acetylgalactosamine and the oxygen atom of serine or threonine residues (reviewed by Hounsell & Feizi, 1982) . This linkage is termed 0-glycosidic (or mucin-type) in distinction from a second type of carbohydrate-protein linkage (N-glycosidic) in which N-acetylglucosamine is joined to the nitrogen of asparagine residues (Kornfeld & Kornfeld, 1980) . The carbohydrate chains of mucins vary greatly in the number of Present address: Department of Biochemistry, Institute of Adaptation Medicine, Shinshu University, Matsumoto 390, Japan.
Abbreviation used: PNL, peanut lectin. Vol. 12 monosaccharides they contain. In spite of this apparent complexity, there appears to be a considerable order in their biosynthesis. Thus, three structurally and antigenically distinct domains, core, backbone and peripheral, are recognized. These are shown schematically in Fig. 1 .
Domains of the carbohydrate chains of mucins
Core regions. Five types of core region structure are known. Biosynthesis of this region may not proceed beyond structure (I) Gal NAc-0-SerlThr
Alternatively chain elongation may occur giving rise to four additional types of core region structure containing galactose and/or N-acetylglucosamine residues linked to Nacetylgalactosamine residues of structure (I) as follows :
r Structure (11) constitutes the blood group T determinant recognized by PNL (Periera et al., 1976) , and this is also expressed on structure (111) and on structure (VI) (see below). Backbone regions. The backbone regions usually consist of alternating galactose and N-acetylglucosamine residues in two types of disaccharide units that are antigenically distinct (Kabat et al., 1982; Gooi et al., 1983a) and termed type 1, Gala1 -+3GlcNAc, and type 2, Galpl-+4GlcNAc (Watkins, 1980) . This region is extremely varied in length and branching pattern and its antigenicity varies accordingly. In linear sequence the disaccharides are joined by 1 -+3 linkage as in structures (X) and (XI), and branched structures are formed by the addition of 1 -+6-linked disaccharide units as in structures (VI j(1X). The short, type-2 branch point sequences (broken underlining), as in structures (V1)-(IX), express the antigenic determinant recognized by a group of human monoclonal antibodies, designated anti-I group 1, among which anti-I Ma is the best characterized . Long and branched type-2 sequences such as structures (VII) and (IX) express the antigenic determinants (solid underlining) recognized by a second group of human monoclonal antibodies, designated anti-I group 2. These include anti-I
Step and anti-I Low (Feizi et Galfil+4GlcNAcfil Galfil+4GlcNAcfil * ~~Galfi1+4GlcNAcf . . Although oligosaccharides (VIIHXI) have not yet been isolated and sequenced from mUCUS glycoproteins, they are presumed to occur in a number of gastrointestinal mucins, e.g. gastric mucins of sheep (Wood et al., 1980 (Wood et al., , 1981 and of man , 1984 , and human ovarian cyst glycoproteins (Wood et al., 1979; Gooi et al., 1983a) , based on immunochemical analyses. The carbohydrate sequence c14 Galfil+4GlcNAc. . .
of structure (VII) was deduced to be a common backbone structure in ovarian cyst mucins (Lloyd & Kabat, 1968) (Watkins, 1980 Waikins, 1980; Kabat, 1982) using mucin-type glycoproteins, in particular, ovarian cyst glycoproteins, as sources of antigenically active oligosaccharides. In recent years the same glycoproteins have been invaluable in the structural eludication of a number of hybridomadefined antigens which behave as tumour-associated or differentiation antigens of man or mouse (Feizi, 19816, 19836,1984 (1968) and were designated X-hapten and Y-hapten respectively (Hakomori & Kobata, 1974) . Furthermore, the same carbohydrate structures may have a different 'marker' role in different animal species. Our studies of the hybridoma antibodies VEP8 and VEP9, which were raised against the human promyelocytic cell line HL60, have shown that both antibodies, like anti-SSEA-1, react strongly with ovarian cyst mucins derived from nonsecrZtors and recognize a1 + 3-fucosylated type-2 chains (Feizi, 19830, Gooi et al., 19836) . This determinant behaves as a myeloid cell-specific antigen among blood cells of man but not those of mouse (S. J. Thorpe, 1982 cited by Feizi, 1983~) . Another peripheral structure which behaves as a tumour-associated antigen in the human colon is a 2 4 3-sialylated Lea structure, recognized by the hybridoma antibody 19.9 (Magnani et al., 1982; Hansson et al., 1983) . This antigen was originally described on glycolipids but is also expressed on gastrointestinal mucins as discussed below.
Monoclonal antibodies in the structural characterization of mucin-type glycoproteins
Since the carbohydrate chains of mucin-type glycoproteins are so heterogeneous and difficult to purify, and the amounts available are often too small for detailed structural characterization, we have used well-characterized monoclonal antibodies as reagents in studies of the carbohydrate chains of membrane-associated glycoproteins of mucin type, as well as those of epithelial mucins. Thus, anti-I and -i antibodies have revealed the presence of linear and branched poly-N-acetyl-lactosamine sequences in mucintype carbohydrate chains of the high molecular weight glycoproteins of B lymphocytes known as 'T 200' glycoproteins (Childs & Feizi, 1981; Childs et af., 1983a) . In addition there is evidence that the sialoglycoprotein GP-2 of bovine erythrocyte membranes (Suzuki et al., 1983 ) is rich in 0-linked oligosaccharides with branched poly-N-acetyllactosamine backbones such as structures (VIII) and (IX) (Y. Suzuki, H. C. Gooi and T. Feizi, cited by Loomes et al., 1984) . Although the native GP-2 has negligible Ii antigen activities, the mild-acid-treated glycoprotein is a most potent inhibitor of anti-I antibodies of groups 1 and 2.
We have obtained structural information on gastrointestinal mucins also by using well-characterized antibodies. Together with PNL and conventional anti-H, Lea and Leb reagents, the monoclonal antibodies anti-I Ma, FC 10.2 and 19.9 have been invaluable in showing (a) marked differences in the carbohydrate chains of mucins derived from the human stomach and distal colon and (b) the changes that occur in neoplasia. These observations are summarized below.
Antigenic markers of the glycoproteins of non-neoplastic mucosae and of tumours of the stomach and distal colon. In studies which have been described in part by Picard et al. (1978) , , 1984 and others which will be described in detail elsewhere, we have used the PNL, anti-I Ma, FC 10.2, 19.9, anti-H, anti-Lea and anti-Leb antibodies to study the expression of their corresponding antigens in paired glycoprotein extracts from the non-neoplastic mucosae and the tumours of patients with carcinoma of the stomach and of the distal colon. The secretor status of the patients was determined by examination of their saliva for A, B and H antigen content (Picard et al., 1978) .
(a) Glycoprotein extracts of stomach. In the glycoprotein extracts of non-neoplastic mucosae of secretors, the blood group H and Leb antigens are strongly expressed (Table 1) . As is well known, these two antigens are lacking or they are found in very low levels in the extracts from non-secretors (for reviews see Watkins, 1980; . In non-secretors, antigens associated with exposed or unsubstituted core regions (PNL receptor) and backbone regions (I Ma and FC 10.2) are strongly expressed ( Table 1) . Abbreviations : N, non-neoplastic mucosae; T, tumour; + , antigen commcnly detected; ( + ), antigen occasionally detected; @, antigen detected among tumour extracts only; f , antigen present in tumour extracts of some individuals but deleted in those of others. In addition the Lea and 19.9 antigens are normally expressed in the gastric mucosal glycoproteins of nonsecretors. On the other hand, when gastric cancers arise in secretors, the five antigens that are normally prominent in non-secretors appear as tumour-associated antigens ( Table  I) . As is well known from the early work of Oh-Uti (1949) and numerous subsequent studies (reviewed by Feizi, 1982) the H, A and B antigens may diminish and even disappear in the glycoprotein extracts of secretors. The five antigens normally expressed in the extracts of non-secretors usually persist at high levels in extracts from the corresponding tumours (Picard et al., 1978 ; J. K. Picard & T. Feizi, unpublished work).
The biochemical basis of the tumour-associated changes in these carbohydrate structures needs investigation. The diminished expression of the H and Leb antigens in the tumours of secretors together with increased expression of antigens associated with their precursors, are likely to be due to incomplete biosynthesis of the blood group chains (Hakomori & Young, 1978) . However, the observations with 19.9 antigen show that there also occurs anomalous sialylation of blood group chains in the tumour tissues of secretors. It will be of interest to establish whether the normal expression of 19.9 antigen in non-secretors and the anomalous expression in tumours of secretors is due to a lack of competition from the blood group H enzymes (fucosyltransferase) or due to the presence of high levels of the galactosyl a2-r 3 sialyltransferase.
From these studies we conclude that the PNL, FC 10.2 and 19.9 determinants are normal antigens in the gastric mucosae of non-secretors (25% of the population are nonsecretors) but they are tumour-associated antigens in 75% of the population who are secretors. None of the seven antigens studied behaves as a tumour marker in the stomach of non-secretors.
(b) Glycoprotein extracts of distal colon. The antigen patterns of glycoprotein extracts of the distal colon differ considerably from those of the stomach. The antigens they express are usually those associated with short type-I backbone structures. Irrespective of secretor status, Lea is the dominant antigen in the glycoproteins from non-neoplastic mucosae of the distal-colon and FC 10.2 is occasionally detected ( Table 1) . As is well known (Szulman, 1966 ) the H and Leb antigens are lacking in this region of the large bowel even in secretors. However, the two latter antigens appear as tumour-associated antigens in the distal colon of secretors (Table 1 ). This was first described by Denk et al. (1974) and it is thought to represent a return to a foetal-like state. The distal colon of the foetus has been found to express the blood group H, A and B antigens until about the time of birth (Szulman, 1966) .
We have observed that the 19.9 antigen appears as a tumour-associated antigen in glycoprotein extracts of the distal colon in approximately half of the patients with carcinoma (Table 1) . This is in agreement with immunocytochemical observations (Arends et al., 1983) and with studies of glycolipid extracts of colon tumours (Hansson ef al., 1983). Thus 19.9 is an example of an antigen which is a normal component in certain tissues of certain individuals and a tumour-associated antigen in others, and whose expression is greatly effected by the secretor gene.
The type-2 based antigens I and i are usually lacking in glycoprotein extracts of the normal mucosae and in primary cancers of the distal colon . These are expressed in a proportion of extracts from metastatic colon tumours (Feizi et al., 1975; J. K. Picard & T. Feizi, unpublished work) . Structural studies are awaited to establish whether the lack of antigens associated with long chain backbone structures such as I, i and FC 10.2, are due to (a) the predominance of short carbohydrate chains in the colorectal mucins or (b) the presence of substituents such as sulphate residues which are known to occur in these mucins and may mask the antigenicity of long chain structures.
Demonstration of the carbohydrate antigens on high molecular weight glycoproteins. The antigenic analyses described above were carried out by quantitative precipitation or haemagglutination inhibition (Picard et al., 1978; or by solid-phase radioimmunoassay (Picard & Feizi, 1984) in which glycoprotein-rich extracts of epithelium or of tumours were used as inhibitors of the binding of monoclonal antibodies to reference glycoproteins. In order to identify the carrier molecules of the carbohydrate antigens, immunostaining of 'Western blots' of the gastric and colonic glycoproteins derived from normal and neoplastic mucosae have been carried out (Fig. 2) using the procedures described previously (Childs et al., 19836) . These studies have confirmed that the FC 10.2, 19.9 and I Ma antigens are expressed on diffusely migrating high molecular weight glycoproteins, a large proportion of which barely enter the 4-1 5% polyacrylamide gradient gels. These are characteristic properties of highly glycosylated macromolecules such as mucins and proteoglycans.
Speculations on the roles of the carbohydrate structures as receptors
We have briefly reviewed knowledge on the structures of carbohydrate moieties of mucin-type glycoproteins with particular reference to the recent observations that these carbohydrate chains express a considerable number of differentiation and tumour-associated antigens recognized by monoclonal antibodies. The roles of these diverse antigens/structures, which are shared by a number of glycoproteins and glycolipids of the cell surface, will be the subject of future investigations. And these will be markedly helped by the availability of well-characterized monoclonal antibodies. In conclusion, we would like to mention some recent observations which we believe are bringing us closer to an understanding of the roles of the blood-group-related family of carbohydrate structures as components of receptor systems.
Monoclonal antibodies to the receptor for epidermal growth factor recognize blood group antigens. Two independent observations on two monoclonal antibodies raised against the receptor for epidermal growth factor of the epidermoid carcinoma cell line A431 have shown that their specificities involve the blood group antigens. In one case the antigen has been shown to be the type-1 blood group H structure (Fredman et al., 1983) and in the other, the blood group A structure (Gooi etal., 1983~) . This latter antibody, TL5, is of special interest. Apparently it binds to a site on the glycoprotein receptor that is distinct from the growth-factorbinding site. However, it has been reported (Schreiber et al., 1983) that when this antibody reacts with human foreskin fibroblasts and is then cross-linked with anti-mouse antibodies, the fibroblasts are stimulated to take up tritiated thymidine. If it can be confirmed that this effect is a result of cross-linking the blood group A-active carbohydrate chains of the epidermal growth factor receptor, this can be taken as evidence that these saccharides are somehow involved in growth regulation.
Galactose-binding tissue lpctin reacts preferentially with Iiactive mucins. A widely distributed animal lectin, galactosebinding protein (Barondes, 1981) , has been shown to react with Ii-active ovarian cyst glycoproteins in preference to those lacking these activities . The same lectin has been found to stimulate in vitro the reactivity of sialyltransferase of bovine milk . (Picard & Feizi, 1984) were reduced with 2-mercaptoethanol, boiled in 2% sodium dodecyl sulphate, electrophoresed in 4-1 5% polyacrylamide gradient gels, transferred on to nitrocellulose paper and incubated with antibodies. Bound mouse and human antibodies were detected by using * 251-labelled anti-mouse and anti-human immunoglobulins as described previously (Childs et al., 1983b) . Abbreviations : N, T, extracts from non-neoplastic mucosae and tumours, respectively; FC, hybridoma antibody FC10.2; 19, hybridoma antibody 19.9; Ma, anti-I Ma; Nm and Nh, normal mouse and human serum respectively.
However, the precise role of the lectin is far from clear. On the other hand, evidence is accumulating on the roles of this family of carbohydrate chains as receptors for infective agents, as discussed below.
Host-cell receptors for Mycoplasma pneumoniae are sialylated oligosaccharides of Ii-antigen type on 0-and N-linked oligosaccharides and glycolipids. We have recently observed that the host-cell receptors for the human pathogen Mycoplasma pneumoniae are long-chain oligosaccharides with sialic acid joined by a2+3 linkage to the terminal galactose residues of poly-N-acetyl-lactosamine sequences of 11-antigen type. These structures may be carried on mucin-type chains as in GP-2 of bovine erythrocyte membranes, as well as the N-linked chains of band 3 protein (Loomes et al., 1984) and glycolipids of erythrocyte membranes (Uemura and coworkers, cited by Loomes et al., 1984) . Although the information is less complete, there are indications that sialylated oligosaccharides of poly-Nacetyl-lactosamine type and their asialo forms may be receptors for the a-toxin of Staphylococcus aereus (Kato & Naiki, 1976) , the haemagglutinin of Sendai virus (Suzuki et al., 1983) and for Streptococcus pneumoniae, respectively (Anderson et al., 1983 ). These observations raise the possibility that receptor systems for infective agents may consist of constellations of glycoproteins and glycolipids with similar carbohydrate structures.
Summary
In this report the carbohydrate antigens expressed on the three oligosaccharide domains, core, backbone and peripheral, of mucin-type glycoproteins are briefly reviewed in the light of recent observations with monoclonal antibodies. These have revealed that a number of cell-surface antigens which behave as tumour-associated and differentiation antigens of man or mouse are abundantly expressed on the carbohydrate chains of a variety of secreted mucins of human and animal origins and they belong to an antigen system which also includes the major blood group antigens. Examples are given of the use of well-characterized anticarbohydrate antibodies to derive structural information on (a) mucin-type glycoproteins of human 3 lymphocyte membranes, (b) the high molecular weight glycoproteins of the normal human gastric and distal-colon mucosae and (c) tumour-derived glycoproteins from these two organs. Major differences between the antigenicities of the normal stomach and distal-coton, and between their tumourderived glycoproteins, and the important effect of the secretor status in the expression of these antigens are described. These observations have enabled a better understanding of the individual and tissue differences in the expression of tumour-associated antigens. The possibility is raised that these carbohydrate structures (many of which also occur on certain N-linked oligosaccharides and glycolipids) are components of receptor systems for endogenous ligands. More tangible evidence is cited for the role of certain structures in this family of saccharides as receptors for infective agents.
